Effects of broccoli sprout with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Journal of Functional Foods

Volumn 4, Issue 4, 2012, Pages 837-841

  Mirmiran, Parvin ^a   Bahadoran, Zahra ^b   Hosseinpanah, Farhad ^b   Keyzad, Amitis ^c   Azizi, Fereidoun ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c National Nutrition and Food Technology Research Institute Tehran   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Broccoli sprouts; Inflammatory markers; Sulforaphane; Type 2 diabetes

Indexed keywords

BRASSICA OLERACEA VAR. ITALICA;

EID: 84866146629     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2012.05.012     Document Type: Article

References (21)

1. Abdin A.A., Baalash A.A., Hamooda H.E. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. Journal of Diabetes and its Complications 2010, 24:168-178.
2. Bahadoran Z., Mirmiran P., Hosseinpanah F., Hedayati M., Hosseinpour-Niazi S., Azizi F. Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. European Journal of Clinical Nutrition 2011, 65:972-977.
3. Castoldi G., Galimberti S., Riva C., Papagna R., Querci F., Casati M., Zerbini G., Caccianiga G., Ferrarese C., Baldoni M., Valsecchi M.G., Stella A. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clinical Science 2007, 113:103-108.
4. Cheung K.L., Khor T.O., Kong A.N. Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Pharmaceutical Research 2009, 26:224-231.
5. Corrales J.J., Almeida M., Burgo R.M., Hernández P., Miralles J.M., Orfao A. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. Journal of Diabetes and its Complications 2007, 21:41-49.
6. Fahey J., Talalay P. Antioxidant function of sulforaphane: a potent inducer of phase 2 detoxyfication enzymes. Food and Chemical Toxicology 1999, 37:973-979.
7. Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. The Journal of Clinical Endocrinolology and Metabolism 2009, 94:3171-3182.
8. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhäuser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. The Journal of Biological Chemistry 2001, 276:32008-32015.
9. Herder C., Schöttker B., Rothenbacher D., Roden M., Kolb H., Müller H., Brenner H. Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: results from the ESTHER study. Atherosclerosis 2011, 216:244-247.
10. King G.L. The role of inflammatory cytokines in diabetes and its complications. Journal of Periodontology 2008, 79:1527-1534.
11. Nyström T. C-reactive protein: a marker or a player?. Clinical Science 2007, 113:79-81.
12. Pfützner A., Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technolology and Therapeutics 2006, 8:28-36.
13. Prawan A., Saw C.L., Khor T.O., Keum Y.S., Yu S., Hu L., Kong A.N. Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chemico-Biological Interactions 2009, 179:202-211.
14. Ree M.A., Huisman M.V., Princen H.M., Meinders A.E., Kluft C. The Diabetes Atorvastatin Lipid Intervention (DALI)-Study Group. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 2003, 166:129-135.
15. Riedl M.A., Saxon A., Diaz-Sanchez D. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clinical Immunology 2009, 130:244-251.
16. Ritz S.A., Wan J., Diaz-Sanchez D. Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am Journal of Physiology- Lung Cellular and Molecular Physiology 2007, 292:33-39.
17. Sjöholm A., Nyström T. Inflammation and the etiology of type 2 diabetes. Diabetes Metabolism Research and Reviews 2006, 22:4-10.
18. Spranger J., Kroke A., Möhlig M., Hoffmann K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52:812-817.
19. Verkerk R., Schreiner M., Krumbein A. Glucosinolates in brassica vegetable: the influence of the food supply chain on intake, bioavailability and human health. Molecular Nutrition and Food Research 2009, 53:219-266.
20. Xue M., Qian Q., Adaikalakoteswari A., Rabbani N., Babaei-Jadidi R., Thornalley P.J. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 2008, 57:2809-2817.
21. Yuan G., Zhou L., Tang J., Yang Y., Gu W., Li F., Hong J., Gu Y., Li X., Ning G., Chen M. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Research and Clinical Practice 2006, 72:244-250.